623 related articles for article (PubMed ID: 20451859)
1. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
4. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
5. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
6. Neuroophthalmological management of optic pathway gliomas.
Lee AG
Neurosurg Focus; 2007; 23(5):E1. PubMed ID: 18004957
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
Avery RA; Bouffet E; Packer RJ; Reginald A
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
[TBL] [Abstract][Full Text] [Related]
8. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA
J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
[TBL] [Abstract][Full Text] [Related]
9. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
[TBL] [Abstract][Full Text] [Related]
10. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
[TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
12. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
13. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications.
Shamji MF; Benoit BG
Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965
[TBL] [Abstract][Full Text] [Related]
14. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
[TBL] [Abstract][Full Text] [Related]
15. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.
Pinheiro SL; Maciel J; Cavaco D; Figueiredo AA; Damásio IL; Donato S; Passos J; Simões-Pereira J
Hormones (Athens); 2023 Mar; 22(1):79-85. PubMed ID: 36269545
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery in optic pathway/hypothalamic gliomas in children.
Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
18. Optic pathway gliomas in adults.
Shofty B; Constantini S; Bokstein F; Ram Z; Ben-Sira L; Freedman S; Vainer G; Kesler A
Neurosurgery; 2014 Mar; 74(3):273-9; discussion 279-80. PubMed ID: 24335817
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
20. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
